» Articles » PMID: 25783760

Protective Role of Insulin-like Growth Factor-1 Receptor in Endothelial Cells Against Unilateral Ureteral Obstruction-induced Renal Fibrosis

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2015 Mar 19
PMID 25783760
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-like growth factor-1 receptor (IGF-1R) can regulate vascular homeostasis and endothelial function. We studied the role of IGF-1R in oxidative stress-induced endothelial dysfunction. Unilateral ureteral obstruction (UUO) was performed in wild-type (WT) mice and mice with endothelial cell (EC)-specific IGF-1R knockout (KO). After UUO in endothelial IGF-1R KO mice, endothelial barrier dysfunction was more severe than in WT mice, as seen by increased inflammatory cell infiltration and vascular endothelial (VE)-cadherin phosphorylation. UUO in endothelial IGF-1R KO mice increased interstitial fibroblast accumulation and enhanced extracellular protein deposition as compared with the WT mice. Endothelial barrier function measured by transendothelial migration in response to hydrogen peroxide (H2O2) was impaired in ECs. Silencing IGF-1R enhanced the influence of H2O2 in disrupting the VE-protein tyrosine phosphatase/VE-cadherin interaction. Overexpression of IGF-1R suppressed H2O2-induced endothelial barrier dysfunction. Furthermore, by using the piggyBac transposon system, we expressed IGF-1R in VE cells in mice. The expression of IGF-1R in ECs also suppressed the inflammatory cell infiltration and renal fibrosis induced by UUO. IGF-1R KO in the VE-cadherin lineage of bone marrow cells had no significant effect on the UUO-induced fibrosis, as compared with control mice. Our results indicate that IGF-1R in the endothelium maintains the endothelial barrier function by stabilization of the VE-protein tyrosine phosphatase/VE-cadherin complex. Decreased expression of IGF-1R impairs endothelial function and increases the fibrosis of kidney disease.

Citing Articles

Association between Expression of Insulin-like Growth Factor-1 (IGF-1), IGF-1 Receptor (IGF-1R), and Hypertension-Mediated Organ Damage (HMOD) Parameters in Leukocytes and Plasma of Children/Adolescents with Primary Hypertension.

Grzywa-Czuba R, Trojanek J, Michalkiewicz J, Kubiszewska I, Obrycki L, Wierzbicka-Rucinska A J Pers Med. 2024; 14(3).

PMID: 38540997 PMC: 10971538. DOI: 10.3390/jpm14030255.


Mechanism of adipose tissue-derived stromal cell-extracellular vesicles in treating oral submucous fibrosis by blocking the TGF-β1/Smad3 pathway via the miR-760-3p/IGF1R axis.

Wang F, Jiang L, Liu P, Jiang Y Biomol Biomed. 2023; 24(4):827-839.

PMID: 38059910 PMC: 11293217. DOI: 10.17305/bb.2023.9944.


Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion.

Dong J, Cao M, Yu H, Dong Y, Han C Ann Transplant. 2022; 27:e937469.

PMID: 36176185 PMC: 9528920. DOI: 10.12659/AOT.937469.


Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms.

Zhao J, Guo S, Schrodi S, He D Front Cell Dev Biol. 2022; 10:937855.

PMID: 35813212 PMC: 9259951. DOI: 10.3389/fcell.2022.937855.


Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.

Kopchick J, Basu R, Berryman D, Jorgensen J, Johannsson G, Puri V Nat Rev Endocrinol. 2022; 18(9):558-573.

PMID: 35750929 PMC: 9703363. DOI: 10.1038/s41574-022-00702-6.


References
1.
Back K, Islam R, Johansson G, Chisalita S, Arnqvist H . Insulin and IGF1 receptors in human cardiac microvascular endothelial cells: metabolic, mitogenic and anti-inflammatory effects. J Endocrinol. 2012; 215(1):89-96. DOI: 10.1530/JOE-12-0261. View

2.
Vestweber D, Winderlich M, Cagna G, Nottebaum A . Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 2008; 19(1):8-15. DOI: 10.1016/j.tcb.2008.10.001. View

3.
Hayashi M, Majumdar A, Li X, Adler J, Sun Z, Vertuani S . VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun. 2013; 4:1672. PMC: 3644080. DOI: 10.1038/ncomms2683. View

4.
Liang A, Wang Y, Han G, Truong L, Cheng J . Chronic kidney disease accelerates endothelial barrier dysfunction in a mouse model of an arteriovenous fistula. Am J Physiol Renal Physiol. 2013; 304(12):F1413-20. PMC: 3680675. DOI: 10.1152/ajprenal.00585.2012. View

5.
Paneni F, Beckman J, Creager M, Cosentino F . Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013; 34(31):2436-43. PMC: 3743069. DOI: 10.1093/eurheartj/eht149. View